Pain

OPTIMA-G

(_Observing _Pain _Transdermal Treatments—_Improving and _Managing _All _GI Symptoms)

Clarity Science is conducting an IRB-approved observational study aimed at evaluating patients’ experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication. Pain and other symptoms will be evaluated by patient answers to validated assessment scales.

Become a Study Investigator

If you are a physician or healthcare provider interested in a minimal risk, observational study to evaluate patient experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication, and you would like to join our OPTIMA-G study, we invite you to apply to Become a Study Investigator.

APPLY NOW

To learn more about our OPTIMA-G study, please call our dedicated Healthcare Provider HelpDesk at

(800) 616-9403.

Principal Investigator

Jeffrey Gudin, MD

Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Englewood, NJ

Clinical Instructor, Anesthesiology
Icahn School of Medicine at Mount Sinai
New York, NY

Study Objective

The purpose of this minimal risk, observational study is to evaluate the patient perceptions of pain treatment and associated symptoms with the use of a topical formulation via a subject and clinician reported surveys over the course of twelve months.

Assessment Tools

The University of Texas MD Anderson Cancer Center has approved and authorized the use of the Brief Pain Inventory (BPI) and Astra Zeneca has approved the Gastrointestinal Symptom Rating Scale (GSRS) as part of the OPTIMA-G Study protocol.

OPTIMA-G Outcomes

Outcomes Pending

Become a Study Investigator

If you are a physician or healthcare provider interested in a minimal risk, observational study to evaluate patient experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication, and you would like to join our OPTIMA-G study, we invite you to apply to Become a Study Investigator.

APPLY NOW

To learn more about our OPTIMA-G study, please call our dedicated Healthcare Provider HelpDesk at

(800) 616-9403.